Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
PureTech Health plc

PureTech Health plc (PRTC) Stock Overview

Explore PureTech Health plc’s financial performance, market position, analyst ratings, and future outlook.

PRTC●NASDAQ
HealthcareBiotechnology
$17.38
$0.36(2.12%)
U.S. Market opens in 8h 21m

PureTech Health plc (PRTC)

Meyka AI Score

Z

Key Financials

Market Cap423.1M
P/E Ratio-0.60
EPS (TTM)$-4.60
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$16.85
3 Months$18.11
1 Year Target$14.56

PRTC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of PureTech Health plc (NASDAQ: PRTC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, PureTech Health plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRTC on the NASDAQ shows an RSI of 50.62, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $14.56 for the NASDAQ listing.

Key metrics behind PureTech Health plc's NASDAQ-traded stock include a P/E ratio of -0.60 and a market capitalization of 423.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRTC on the NASDAQ.

Price Performance (NASDAQ: PRTC)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.91%
3-Month Change
0.17%
6-Month Change
-6.91%
Year-to-Date (YTD) Change
4.45%
1-Year Change
-11.19%
3-Year Change
-39.23%
5-Year Change
-63.56%
All-Time (Max) Change
-54.86%

Contact Information

https://puretechhealth.com
617 482 2333
6 Tide Street, Boston, MA, 02210

Company Facts

560 Employees
IPO DateNov 16, 2020
CountryUS
Actively Trading

Frequently Asked Questions